BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25187436)

  • 1. Effect of fluid and dietary sodium restriction in the management of patients with heart failure and preserved ejection fraction: study protocol for a randomized controlled trial.
    d'Almeida KS; Rabelo-Silva ER; Souza GC; Trojahn MM; Barilli SL; Mansson JV; Biolo A; Rohde LE; Clausell N; Beck-da-Silva L
    Trials; 2014 Sep; 15():347. PubMed ID: 25187436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive fluid and sodium restriction in decompensated heart failure with preserved ejection fraction: Results from a randomized clinical trial.
    Machado d'Almeida KS; Rabelo-Silva ER; Souza GC; Trojahn MM; Santin Barilli SL; Aliti G; Rohde LE; Biolo A; Beck-da-Silva L
    Nutrition; 2018 Oct; 54():111-117. PubMed ID: 29793053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial.
    Aliti GB; Rabelo ER; Clausell N; Rohde LE; Biolo A; Beck-da-Silva L
    JAMA Intern Med; 2013 Jun; 173(12):1058-64. PubMed ID: 23689381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a diuretic adjustment algorithm and nonpharmacologic management in patients with heart failure: study protocol for a randomized controlled trial.
    Feijó MK; Biolo A; Ruschel KB; Orlandin L; Aliti GB; Rabelo-Silva ER
    Trials; 2015 Feb; 16():44. PubMed ID: 25885424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction.
    Bello NA; Claggett B; Desai AS; McMurray JJ; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; Solomon SD
    Circ Heart Fail; 2014 Jul; 7(4):590-5. PubMed ID: 24874200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K; Park TH
    Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure (GOURMET-HF).
    Wessler JD; Maurer MS; Hummel SL
    Am Heart J; 2015 Mar; 169(3):342-348.e4. PubMed ID: 25728723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yoga and breathing technique training in patients with heart failure and preserved ejection fraction: study protocol for a randomized clinical trial.
    Lopes CP; Danzmann LC; Moraes RS; Vieira PJC; Meurer FF; Soares DS; Chiappa G; Guimarâes LSP; Leitão SAT; Ribeiro JP; Biolo A
    Trials; 2018 Jul; 19(1):405. PubMed ID: 30055633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
    Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
    Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Casado J; Sánchez M; Garcés V; Manzano L; Cerqueiro JM; Epelde F; García-Escrivá D; Pérez-Silvestre J; Morales JL; Montero-Pérez-Barquero M;
    Int J Cardiol; 2017 Sep; 243():332-339. PubMed ID: 28528982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure.
    Parrinello G; Di Pasquale P; Licata G; Torres D; Giammanco M; Fasullo S; Mezzero M; Paterna S
    J Card Fail; 2009 Dec; 15(10):864-73. PubMed ID: 19944363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
    Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
    Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction.
    Badheka AO; Rathod A; Kizilbash MA; Bhardwaj A; Ali O; Afonso L; Jacob S
    Am J Cardiol; 2011 Nov; 108(9):1283-8. PubMed ID: 21855829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in dietary intake and nutritional status associated with a significant reduction in sodium intake in patients with heart failure. A sub-analysis of the SODIUM-HF pilot study.
    Colin-Ramirez E; McAlister FA; Zheng Y; Sharma S; Ezekowitz JA
    Clin Nutr ESPEN; 2016 Feb; 11():e26-e32. PubMed ID: 28531423
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.